Latest / Concord News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Concord News
FDA just greenlit lecanemab, the first drug in years to target Alzheimer’s amyloid plaques — offering hope to early-stage patients by slowing cognitive decline, though with risks like brain swelling and bleeding, doctors must tread carefully as this new treatment reshapes the fight against the disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.